2024-09-10 |
NXGWHYDCNZ91585 |
RISING PHARMA HOLDINGS INC |
4322.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-08-29 |
DSVFBOM8121807 |
HERITAGE PHARMACEUTICALS DBA AVET P |
2255.0 kg |
310510
|
FILODIPINE ER TABLETS |
2024-08-29 |
DSVFBOM8120402 |
HERITAGE PHARMACEUTICALS DBA AVET P |
2902.0 kg |
310510
|
FILODIPINE ER TABLETS |
2024-08-27 |
DSVFBOM8120753 |
HERITAGE PHARMACEUTICALS DBA AVET P |
7496.0 kg |
310510
|
FILODIPINE ER TABLETS |
2024-07-30 |
FJLAJF02SEH29921 |
SST CORP |
13770.0 kg |
291229
|
METFORMIN HYDROCHLORIDE USP 100 |
2024-07-30 |
CUIACTLMU2403165 |
SST CORP |
2804.0 kg |
291229
|
MET. HYDROCHLORIDE USP . |
2024-07-27 |
NXGWHYDCMF72046 |
RISING PHARMA HOLDINGS INC |
1899.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-07-10 |
DSVFBOM8119140 |
HERITAGE PHARMACEUTICALS DBA AVET P |
6375.0 kg |
310510
|
FILODIPINE ER TABLETS |
2024-07-08 |
NXGWHYDCLP43933 |
RISING PHARMA HOLDINGS INC |
993.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-06-02 |
NEDFHYDCKX35274 |
RISING PHARMA HOLDINGS INC |
1184.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-05-18 |
NEDFHYDCKD32890 |
RISING PHARMA HOLDINGS INC |
2718.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-04-23 |
NEDFHYDCJT11986 |
RISING PHARMA HOLDINGS INC |
1728.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-04-01 |
DSVFBOM8114247 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4817.0 kg |
310510
|
FILODIPINE ER TABLETS |
2024-03-13 |
NEDFHYDCHL55855 |
RISING PHARMA HOLDINGS INC |
1204.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-03-02 |
DSVFBOM8112231 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4522.0 kg |
310510
|
FILODIPINE ER TABLETS |
2024-02-27 |
NEDFHYDCGL95290 |
RISING PHARMA HOLDINGS INC |
2688.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-02-01 |
DSVFBOM8110891 |
HERITAGE PHARMACEUTICALS DBA AVET P |
3428.0 kg |
310510
|
FILODIPINE ER TABLETS |
2024-01-22 |
NEDFHYDCFV85605 |
RISING PHARMA HOLDINGS INC |
916.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2024-01-21 |
DSVFBOM8109555 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4357.0 kg |
310510
|
FILODIPINE ER TABLETS |
2024-01-21 |
DSVFBOM8109419 |
AVET PHARMACEUTICALS INC |
4902.0 kg |
310510
|
FILODIPINE ER TABLETS |
2023-12-14 |
DSVFBOM8108163 |
AVET PHARMACEUTICALS INC |
4166.0 kg |
310510
|
FELODIPINE ER TABLETS |
2023-11-18 |
NEDFHYDCDZ76645 |
RISING PHARMA HOLDINGS INC |
557.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2023-11-08 |
DSVFBOM8106612 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4451.0 kg |
310510
|
DOXYCYCLINE TABLETS |
2023-10-20 |
NEDFHYDCDC94832 |
RISING PHARMA HOLDINGS INC |
2743.0 kg |
300390
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
2023-10-19 |
DSVFBOM8106010 |
HERITAGE PHARMACEUTICALS DBA AVET P |
5819.0 kg |
310510
|
DOXYCYCLINE TABLETS |
2023-10-02 |
DSVFBOM8105154 |
HERITAGE PHARMACEUTICALS DBA AVET P |
5819.0 kg |
310510
|
GLYBURIDE TABLETS |
2023-09-28 |
DSVFBOM8104859 |
HERITAGE PHARMACEUTICALS DBA AVET P |
5239.0 kg |
310510
|
GLYBURIDE TABLETS |
2023-09-05 |
DSVFBOM8103770 |
AVET PHARMACEUTICALS INC |
4811.0 kg |
310510
|
GLYBURIDE TABLETS |
2023-08-09 |
DSVFBOM8106770 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4144.0 kg |
310510
|
DOXYCYCLINE TABLETS |
2023-08-09 |
DSVFBOM8102294 |
AVET PHARMACEUTICALS INC |
6703.0 kg |
310510
|
DOXYCYCLINE TABLETS 50 MG |
2023-08-05 |
NEDFHYDCAP94964 |
RISING PHARMA HOLDINGS INC |
3281.0 kg |
300490
|
MEDICAMENTS, IN MEASURED DOSES, RETAIL PACKI G |
2023-07-19 |
NEDFHYDBZS26640 |
RISING PHARMA HOLDINGS INC |
2244.0 kg |
300490
|
MEDICAMENTS, IN MEASURED DOSES, RETAIL PACKI G |
2023-07-07 |
DSVFBOM8100719 |
AVET PHARMACEUTICALS INC |
2862.0 kg |
310510
|
GLYBURIDE TABLETS |
2023-06-07 |
DSVFBOM8098986 |
AVET PHARMACEUTICALS INC |
4230.0 kg |
300420
|
TOTAL 2755 PACKAGES 14 PALLETS)(2755 PACKAGESPACKED IN DOXYCYCLINE TABLETS 100 MG,50S USB ATCH NO:18036088,18036089 MFG. DATE:MAR-2023 EXP.DATE:FEB-2026DOXYCYCLINE TABLETS 100 MG,500S USBATCH NO:18036011,18036012 MFG.DATE:MAR-2023 EXP.DATE:FEB-2026HS CODE:30042049INVOICE NO:1107003486 DT:29.04.2023INVOICE NO:11070 03487 DT:29.04.2023S/B NO:TOTAL NET WT:3111.470 KGSTOTAL GROSS WT:4229.756 KGSFREIGHT COLLECT |
2023-06-07 |
DSVFBOM8098984 |
AVET PHARMACEUTICALS INC |
2976.0 kg |
310510
|
GLYBURIDE TABLETS |
2023-05-08 |
NEDFHYDBXW20053 |
RISING PHARMA HOLDINGS INC |
980.0 kg |
300490
|
MEDICAMENTS, IN MEASURED DOSES, RETAIL PACKI G |
2023-05-05 |
DSVFBOM8097429 |
AVET PHARMACEUTICALS INC |
5835.0 kg |
310510
|
DOXYCYCLINE TABLETS 100 MG |
2023-05-05 |
DSVFBOM8097426 |
AVET PHARMACEUTICALS INC |
5470.0 kg |
850434
|
GLIPIZIDE 5MG & METFORMIN HCL 500 M |
2023-05-05 |
DSVFBOM8097533 |
AVET PHARMACEUTICALS INC |
3349.0 kg |
310510
|
DOXYCYCLINE TABLETS |
2023-04-24 |
DSVFBOM8096018 |
HERITAGE PHARMACEUTICALS DBA AVET P |
3508.0 kg |
|
MEIDICNE |
2023-04-24 |
DSVFBOM8096819 |
AVET PHARMACEUTICALS INC |
5243.0 kg |
310510
|
DOXYCYCLINE TABLETS 100 MG |
2023-04-12 |
NEDFHYDBWZ35774 |
RISING PHARMA HOLDINGS INC |
1233.0 kg |
300490
|
MEDICAMENTS, IN MEASURED DOSES, RETAIL PACKI G |
2023-03-16 |
NEDFHYDBVY80134 |
RISING PHARMA HOLDINGS INC |
2710.0 kg |
300490
|
MEDICAMENTS, IN MEASURED DOSES, RETAIL PACKI G |
2023-03-10 |
DSVFBOM8094731 |
AVET PHARMACEUTICALS INC |
6460.0 kg |
300230
|
MEDICINE |
2023-03-10 |
DSVFBOM8094657 |
AVET PHARMACEUTICALS INC |
1451.0 kg |
|
MEDCINE |
2023-02-15 |
DSVFBOM8093272 |
AVET PHARMACEUTICALS INC |
1584.0 kg |
300230
|
MEDICINE |
2023-02-02 |
CMDUAMC2016223 |
RISING PHARMA HOLDINGS INC |
9549.0 kg |
300490
|
CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS 30 PALLETS CONSISTING OF 1140 SHIPPERS NETAGLINIDE TABLETS 120MG, 90 S US HS CODE: 30049099 NETAGLINIDE TABLETS 60MG, 90 S US HS CODE: 30049099 NETAGLINIDE TABLETS 60MG, 90 S US HS CODE: 30049099 INVOICE NO:1107003146, 1107003149 110700315 DT: 31.12.2022 NET WT: 3044.72 KGS SB NO:6666781, 6667531 6669723 DT: 03.01.2023 FREIGHT PREPAID |
2023-02-01 |
DSVFBOM8093098 |
AVET PHARMACEUTICALS INC |
4104.0 kg |
300420
|
1289 PACKAGES1289 PACKAGES PACKED IN 21 PALLETSDOXYCYCLINE TABLETS 50 MG,BATCH NO:18035547,18035546MFG. DT:OCT-2022EXP.DT:SEP-2025HS CODE:30042049GLYBURIDE TABLETS USP 5 MGBATCH NO:18035519,18035504MFG. DT:OCT-2022EXP.DT:SEP-2025NARATRIPTAN TABLETS USP 2.5 MGBATCH NO:18035515MFG. DT:OCT-2022EXP.DT:SEP-2025HS CODE: 30049099DESIPRAMINE HCI TAB USP 100 MGBATCH NO:18035574MFG.DT:NOV-2022EXP.DT:OCT-2025HS CODE:30049099INVOICE NO:1107003120 DT:28/12/2022INVOICE NO:110700 |
2022-12-19 |
NEDFHYDBSK74164 |
RISING PHARMA HOLDINGS INC |
757.0 kg |
300490
|
MEDICAMENTS, IN MEASURED DOSES, RETAIL PACKI G |
2022-12-07 |
DSVFBOM8090297 |
HERITAGE PHARMACEUTICALS DBA AVET P |
4201.0 kg |
|
1 X 40 RF |